Gasmi Mehdi
Director at Avalanche Biotechnologies, Inc.
- Sold, on record
- $2.8M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Jul 20, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Avalanche Biotechnologies, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedFeb 12, 2020 2020
Sold 10,000 shares at $15.07 ($151k)
Gasmi Mehdi, Director
Sold 3.7% of holdings ($4.1M position)258,979 shares leftFirst sale on recordFiling
- 2 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedFeb 18, 2020 +6 days
Sold 5,000 shares at $16.23 ($81k)
Gasmi Mehdi, Director
Sold 1.9% of holdings ($4.3M position)258,979 shares leftFiling
- 3 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedMay 18, 2020 +90 days
Sold 40,000 shares at $18.85 ($754k)
Gasmi Mehdi, Director
Sold 12.7% of holdings ($5.9M position)274,442 shares leftFiling
- 4 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedMay 20, 2020 +2 days
Sold 1,401 shares at $20.01 ($28k)
Gasmi Mehdi, Director
Sold 0.5% of holdings ($5.5M position)274,442 shares left0.1x usual sizeFiling
- 5 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedJun 15, 2020 +26 days
Sold 10,000 shares at $21.86 ($219k)
Gasmi Mehdi, Director
Sold 3.5% of holdings ($6.2M position)274,442 shares left1.3x usual sizeFiling
- 6 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedJun 18, 2020 +3 days
Sold 11,395 shares at $25.01 ($285k)
Gasmi Mehdi, Director
Sold 4% of holdings ($7.1M position)274,442 shares left1.1x usual sizeFiling
- 7 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedJun 22, 2020 +4 days
Sold 23,605 shares at $25.06 ($592k)
Gasmi Mehdi, Director
Sold 7.9% of holdings ($7.5M position)274,442 shares left2.4x usual sizeFiling
- 8 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedJul 20, 2020 +28 days
Sold 5,000 shares at $17.60 ($88k)
Gasmi Mehdi, Director
Sold 1.8% of holdings ($4.9M position)274,442 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2020 | Jul 22, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 5,000 | $88k | 1.8% | Plan not stated | SEC |
| Jun 22, 2020 | Jun 23, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 23,605 | $592k | 7.9% | Plan not stated | SEC |
| Jun 18, 2020 | Jun 18, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 11,395 | $285k | 4.0% | Plan not stated | SEC |
| Jun 15, 2020 | Jun 17, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 10,000 | $219k | 3.5% | Plan not stated | SEC |
| May 20, 2020 | May 22, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 1,401 | $28k | 0.5% | Plan not stated | SEC |
| May 18, 2020 | May 20, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 40,000 | $754k | 12.7% | Plan not stated | SEC |
| Feb 18, 2020 | Feb 20, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 5,000 | $81k | 1.9% | Plan not stated | SEC |
| Feb 12, 2020 | Feb 14, 2020 | Avalanche Biotechnologies, Inc. | Director | Form 4 sale | 10,000 | $151k | 3.7% | Plan not stated | SEC |
| Jun 15, 2015 | Jun 17, 2015 | Avalanche Biotechnologies, Inc. | SVP,Pharmaceutical Development | Form 4 sale | 500 | $20k | 6.7% | Plan not stated | SEC |
| Jun 8, 2015 | Jun 10, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 500 | $19k | 6.7% | Plan not stated | SEC |
| May 28, 2015 | May 29, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 500 | $19k | 6.7% | Plan not stated | SEC |
| May 21, 2015 | May 22, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 500 | $19k | 6.7% | Plan not stated | SEC |
| May 14, 2015 | May 15, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 500 | $18k | 6.7% | Plan not stated | SEC |
| May 7, 2015 | May 8, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 500 | $17k | 6.7% | Plan not stated | SEC |
| Apr 28, 2015 | Apr 30, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 1,000 | $36k | 12.5% | Plan not stated | SEC |
| Apr 21, 2015 | Apr 23, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 1,000 | $39k | 100.0% | Unusual | SEC |
| Apr 14, 2015 | Apr 15, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 1,000 | $39k | 100.0% | Unusual | SEC |
| Apr 7, 2015 | Apr 8, 2015 | Avalanche Biotechnologies, Inc. | VP, Pharmaceutical Development | Form 4 sale | 9,000 | $347k | 100.0% | Unusual | SEC |